Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP421868.RAF2I2jtsi3gByFlMBr8Irq3NkANTMULNErNgyaztTFnY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP421868.RAF2I2jtsi3gByFlMBr8Irq3NkANTMULNErNgyaztTFnY130_assertion type Assertion NP421868.RAF2I2jtsi3gByFlMBr8Irq3NkANTMULNErNgyaztTFnY130_head.
- NP421868.RAF2I2jtsi3gByFlMBr8Irq3NkANTMULNErNgyaztTFnY130_assertion description "[Conversely, expression of the dominant negative type II receptor decreased the latency of Neu-induced mammary tumor formation while significantly reducing the incidence of extravascular lung metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421868.RAF2I2jtsi3gByFlMBr8Irq3NkANTMULNErNgyaztTFnY130_provenance.
- NP421868.RAF2I2jtsi3gByFlMBr8Irq3NkANTMULNErNgyaztTFnY130_assertion evidence source_evidence_literature NP421868.RAF2I2jtsi3gByFlMBr8Irq3NkANTMULNErNgyaztTFnY130_provenance.
- NP421868.RAF2I2jtsi3gByFlMBr8Irq3NkANTMULNErNgyaztTFnY130_assertion SIO_000772 12808151 NP421868.RAF2I2jtsi3gByFlMBr8Irq3NkANTMULNErNgyaztTFnY130_provenance.
- NP421868.RAF2I2jtsi3gByFlMBr8Irq3NkANTMULNErNgyaztTFnY130_assertion wasDerivedFrom befree-20150227 NP421868.RAF2I2jtsi3gByFlMBr8Irq3NkANTMULNErNgyaztTFnY130_provenance.
- NP421868.RAF2I2jtsi3gByFlMBr8Irq3NkANTMULNErNgyaztTFnY130_assertion wasGeneratedBy ECO_0000203 NP421868.RAF2I2jtsi3gByFlMBr8Irq3NkANTMULNErNgyaztTFnY130_provenance.